Zobrazeno 1 - 6
of 6
pro vyhledávání: '"I B Skottheim"'
Autor:
Tommy B. Andersson, Espen Molden, Hege Christensen, I B Skottheim, Rune Sandbu, Maria Ulvestad, J Hjelmesæth, Sara Bremer, Gunn Signe Jakobsen, Anders Åsberg
Publikováno v:
Clinical Pharmacology & Therapeutics. 93:275-282
Individual variability in expression and function of organic anion-transporting polypeptide 1B1 (OATP1B1), multidrug resistance protein 1 (MDR1), and/or cytochrome P450 3A4 (CYP3A4) may impact the clinical response of many drugs. We investigated the
Publikováno v:
Molecular Diagnosis & Therapy. 15:221-227
Background: Myopathic complaints are common in the general population and are more frequent with increasing age. When myopathic symptoms arise in a patient treated with a HMG-CoA reductase inhibitor (statin), it is always a question of whether the sy
Publikováno v:
European Journal of Pharmaceutical Sciences. 33:317-325
Statins exist in both acid and lactone forms in vivo. High plasma levels of the lactone forms have been observed in patients with statin induced myopathy. In the present study, the hypothesis that lactone forms have a higher potency of inducing myoto
Autor:
Hege Christensen, I B Skottheim, Rune Sandbu, Kjell Morten Stormark, J Hjelmesæth, Gunn Signe Jakobsen, Trond Jenssen, Anders Åsberg
Publikováno v:
Clinical pharmacology and therapeutics. 87(6)
Biliopancreatic diversion with duodenal switch is a combined restrictive and malabsorptive surgical weight loss procedure. Given that this procedure introduces a bypass of the proximal small intestine, it is a suitable model for investigating the inf
Autor:
M Ulvestad, I. B. Skottheim, G Signe Jakobsen, S Bremer, E Molden, A Åsberg, Jøran Hjelmesaeth, T. B. Andersson, R Sandbu, H Christensen
Publikováno v:
Clinical Pharmacology & Therapeutics. 97:428-428
Autor:
Gunn Signe Jakobsen, Hege Christensen, Jo Røislien, Anders Åsberg, I B Skottheim, Rune Sandbu, Jøran Hjelmesæth
Publikováno v:
Surgical Endoscopy
Background A previous study of 22 patients undergoing either gastric bypass or duodenal switch showed increased systemic exposure of atorvastatin acid 3–8 weeks after surgery in the majority of patients. This study aimed to investigate the long-ter